Supernus Pharmaceuticals reported $234.71M in Current Liabilities for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Aerie Pharmaceuticals AERI:US $ 124.99M 6.86M
Aurora Cannabis Inc ACB:CN 122.86M 2.47M
Canopy Growth Corp WEED:CN C$ 239.25M 20.66M
Corcept Therapeutics CORT:US $ 47.54M 2.78M
Eisai 4523:JP Y 304993M 24164M